167 related articles for article (PubMed ID: 16332439)
21. 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro.
O'Reilly KC; Trent S; Bailey SJ; Lane MA
Exp Biol Med (Maywood); 2007 Oct; 232(9):1195-203. PubMed ID: 17895527
[TBL] [Abstract][Full Text] [Related]
22. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives.
Jiao PF; Zhao BX; Wang WW; He QX; Wan MS; Shin DS; Miao JY
Bioorg Med Chem Lett; 2006 Jun; 16(11):2862-7. PubMed ID: 16563757
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.
Bojarski AJ; Kuran B; Kossakowski J; Kozioł A; Jagiełło-Wójtowicz E; Chodkowska A
Eur J Med Chem; 2009 Jan; 44(1):152-64. PubMed ID: 18486277
[TBL] [Abstract][Full Text] [Related]
25. Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity.
Iceta R; Mesonero JE; Aramayona JJ; Alcalde AI
J Physiol Pharmacol; 2009 Mar; 60(1):157-64. PubMed ID: 19439818
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
Pessoa-Mahana H; González-Lira C; Fierro A; Zapata-Torres G; Pessoa-Mahana CD; Ortiz-Severin J; Iturriaga-Vásquez P; Reyes-Parada M; Silva-Matus P; Saitz-Barría C; Araya-Maturana R
Bioorg Med Chem; 2013 Dec; 21(24):7604-11. PubMed ID: 24262884
[TBL] [Abstract][Full Text] [Related]
27. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.
Maurel JL; Autin JM; Funes P; Newman-Tancredi A; Colpaert F; Vacher B
J Med Chem; 2007 Oct; 50(20):5024-33. PubMed ID: 17803293
[TBL] [Abstract][Full Text] [Related]
28. 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function.
Ilas J; Jakopin Z; Borstnar T; Stegnar M; Kikelj D
J Med Chem; 2008 Sep; 51(18):5617-29. PubMed ID: 18729445
[TBL] [Abstract][Full Text] [Related]
29. [Design, synthesis and bioactivity of aryl piperazine benzo[b][1,4]oxazine derivatives].
Zheng YY; Xie P; Zhang J; Li JQ; Guo L; Yu LP; Zhou B
Yao Xue Xue Bao; 2012 Jun; 47(6):755-63. PubMed ID: 22919723
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
Herold F; Król M; Kleps J; Nowak G
Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.
Shen Z; Siva Ramamoorthy P; Hatzenbuhler NT; Evrard DA; Childers W; Harrison BL; Chlenov M; Hornby G; Smith DL; Sullivan KM; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2010 Jan; 20(1):222-7. PubMed ID: 19932965
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
Dounay AB; Barta NS; Campbell BM; Coleman C; Collantes EM; Denny L; Dutta S; Gray DL; Hou D; Iyer R; Maiti SN; Ortwine DF; Probert A; Stratman NC; Subedi R; Whisman T; Xu W; Zoski K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1114-7. PubMed ID: 20031410
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
34. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.
Herold F; Izbicki Ł; Chodkowski A; Dawidowski M; Król M; Kleps J; Turło J; Wolska I; Nowak G; Stachowicz K; Dybała M; Siwek A; Nowak M; Pieniazek E; Jarończyk M; Sylte I; Mazurek AP
Eur J Med Chem; 2009 Nov; 44(11):4702-15. PubMed ID: 19665823
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.
Vercouillie J; Mavel S; Galineau L; Ragusa T; Innis R; Kassiou M; Chalon S; Dollé F; Besnard JC; Guilloteau D; Emond P
Bioorg Med Chem Lett; 2006 Mar; 16(5):1297-300. PubMed ID: 16337793
[TBL] [Abstract][Full Text] [Related]
36. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
Silanes SP; Orús L; Oficialdegui AM; Martínez Esparza J; Lasheras B; Del Río J; Monge A
Pharmazie; 2004 Jul; 59(7):499-501. PubMed ID: 15296084
[TBL] [Abstract][Full Text] [Related]
37. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.
Wang S; Chen Y; Liu X; Xu X; Liu X; Liu BF; Zhang G
Arch Pharm (Weinheim); 2014 Jan; 347(1):32-41. PubMed ID: 24214603
[TBL] [Abstract][Full Text] [Related]
39. Quantitative structure-activity relationship analysis of aryl alkanol piperazine derivatives with antidepressant activities.
Chen KX; Li ZG; Xie HY; Gao JR; Zou JW
Eur J Med Chem; 2009 Nov; 44(11):4367-75. PubMed ID: 19581024
[TBL] [Abstract][Full Text] [Related]
40. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]